These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 16575879)

  • 1. Ifosfamide-induced nephrotoxicity in oncological patients.
    Quiroz-Aldave JE; Durand-Vásquez MDC; Chávez-Vásquez FS; Rodríguez-Angulo AN; Gonzáles-Saldaña SE; Alcalde-Loyola CC; Coronado-Arroyo JC; Zavaleta-Gutiérrez FE; Concepción-Urteaga LA; Haro-Varas JC; Concepción-Zavaleta MJ
    Expert Rev Anticancer Ther; 2024; 24(1-2):5-14. PubMed ID: 38031874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A molecular model of the enantioselective liquid chromatographic separation of (R,S)-ifosfamide and its N-dechloroethylated metabolites on a teicoplanin aglycon chiral stationary phase.
    Ravichandran S; Collins JR; Singh N; W Wainer I
    J Chromatogr A; 2012 Dec; 1269():218-25. PubMed ID: 22917979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective liquid chromatography-mass spectrometry assay for the determination of ifosfamide and identification of the N-dechloroethylated metabolites of ifosfamide in human plasma.
    Oliveira RV; Onorato JM; Siluk D; Walko CM; Lindley C; Wainer IW
    J Pharm Biomed Anal; 2007 Oct; 45(2):295-303. PubMed ID: 17855037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and quantification of (R) and (S)-dechloroethylifosfamide metabolites in plasma from children by enantioselective LC/MS/MS.
    Aleksa K; Nava-Ocampo A; Koren G
    Chirality; 2009 Jul; 21(7):674-80. PubMed ID: 18825700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity.
    Aleksa K; Matsell D; Krausz K; Gelboin H; Ito S; Koren G
    Pediatr Nephrol; 2005 Jul; 20(7):872-85. PubMed ID: 15875221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tubule cell model for ifosfamide nephrotoxicity.
    Aleksa K; Halachmi N; Ito S; Koren G
    Can J Physiol Pharmacol; 2005 Jun; 83(6):499-508. PubMed ID: 16049550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal ontogeny of ifosfamide nephrotoxicity.
    Aleksa K; Halachmi N; Ito S; Koren G
    J Lab Clin Med; 2004 Dec; 144(6):285-93. PubMed ID: 15614250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal clearance of ifosfamide.
    Springate J; Zamlauski-Tucker MJ; Lu H; Chan KK
    Drug Metab Dispos; 1997 Sep; 25(9):1081-2. PubMed ID: 9311624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective metabolism of ifosfamide by the kidney.
    Aleksa K; Ito S; Koren G
    Chirality; 2006 Jun; 18(6):398-405. PubMed ID: 16575879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies.
    Aleksa K; Woodland C; Koren G
    Pediatr Nephrol; 2001 Dec; 16(12):1153-8. PubMed ID: 11793120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclophosphamide versus ifosfamide: to use ifosfamide or not to use, that is the three-dimensional question.
    Williams ML; Wainer IW
    Curr Pharm Des; 1999 Aug; 5(8):665-72. PubMed ID: 10469897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ifosfamide. Metabolic studies, new therapeutic approaches and new analogs.
    Misiura K
    Mini Rev Med Chem; 2006 Apr; 6(4):395-400. PubMed ID: 16613576
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.